DaVita Clinical Research Expands in Denver
DaVita Clinical Research, a provider of clinical research services focused on kidney research and a variety of other specialty therapeutic populations, announced an agreement to enter the St. Anthony Hospital campus in Lakewood, Colo. The 80-bed facility will be operational in early 2012 and is expected to create more than 50 specialized research jobs.
“We are excited about our partnership with a hospital that has such a strong reputation with healthcare professionals and patients throughout Colorado,” said Kent Thiry, DaVita Chairman and CEO.
The hospital-based site increases DCR’s physical capacity from 42 to 122 beds in North America. The facility will support high-risk studies and an expanded ability to support normal, healthy volunteer Phase I clinical studies. The custom-designed facility will provide DCR with the capacity needed to grow its clinical research business in existing specialty populations, including renal patients.
The 35,000-square-foot unit will be physically connected to St. Anthony Hospitalin Medical Office Plaza South. St. Anthony Hospital, a full-service hospital and Level I Trauma Center, opened its doors in Lakewood in June 2011 after 119 years in its central Denver location.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
